Clarivate Sells Life Sciences Unit to Altaris for $600M
LONDON, July 6, 2026 Clarivate Plc has announced a definitive agreement to sell its Life Sciences & Healthcare (LS&H)...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LONDON, July 6, 2026 Clarivate Plc has announced a definitive agreement to sell its Life Sciences & Healthcare (LS&H)...
MENLO PARK, Calif., June 29, 2026 BillionToOne has announced the publication of a peer-reviewed clinical study demonstrating that its...
NEW YORK, June 30, 2026 Inductive Bio, Inc. has announced its integration into Anthropic’s Connector Ecosystem for Life Sciences,...
LONDON, June 25, 2026 Evaluate, a Norstella company and a leading provider of pharmaceutical market intelligence, has been recognized...
DARMSTADT, Germany & MINNEAPOLIS, June 25, 2026 Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire Bio-Techne...
MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...
WARSAW, Poland, June 3, 2026 Ingenix, an emerging artificial intelligence company focused on transforming drug discovery through advanced biological...
Stockholm, Sweden | April 30, 2026 Moleculent has announced the successful closing of a $20 million financing round, aimed...
Brussels, Belgium & Atlanta, Georgia – March 24, 2026 Strategic Biologics Expansion to Strengthen Global Supply In a major...
Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...
